TheraRadar
Clinical-Stage Companies / Materia Medica Holding

Materia Medica Holding

Pre-Approval PRO BETA
38
Total Trials
24
Phase 3
0
Phase 2
4
Recruiting
365
Score

Pipeline by Phase

Phase 3
24
Phase 2
Phase 1

Therapeutic Focus

Influenza Acute Respiratory Viral Infection Acute Respiratory Viral Infections Obesity Acute Upper Respiratory Tract Infections

Clinical Trials (38)

NCT06901297 Phase 3 RECRUITING

The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

Started: 4/3/2025

NCT06715891 Phase 3 RECRUITING

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Started: 11/11/2024

NCT07171099 Phase 3 RECRUITING

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

Started: 10/3/2025

NCT06284265 Phase 3 ACTIVE NOT RECRUITING

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Started: 10/16/2023

NCT06263881 Phase 3 COMPLETED

Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

Started: 12/1/2023

NCT05364671 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Started: 4/29/2022

NCT05069649 Phase 3 COMPLETED

Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

Started: 10/6/2021

NCT04295681 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

Started: 12/12/2019

NCT04552041 Phase 3 COMPLETED

Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.

Started: 12/3/2020

NCT04918771 Phase 3 COMPLETED

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Started: 4/29/2021

NCT05074888 Phase 3 COMPLETED

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Started: 10/15/2021

NCT04569357 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

Started: 11/20/2020

NCT03159104 Phase 3 COMPLETED

Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children

Started: 8/25/2015

NCT04250311 Phase 3 SUSPENDED

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

Started: 12/12/2019

NCT04244084 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

Started: 10/8/2019

NCT01570829 Phase 3 COMPLETED

Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients

Started: 12/1/2011

NCT03815292 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke

Started: 10/19/2018

NCT03725033 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Started: 10/10/2018

NCT01765920 Phase 3 COMPLETED

Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults

Started: 12/1/2012

NCT03159611 Phase 3 COMPLETED

Efficacy and Safety Clinical Trial of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury

Started: 2/19/2016

NCT01843842 Phase 3 COMPLETED

Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children

Started: 4/1/2013

NCT01716104 Phase 3 COMPLETED

Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression

Started: 11/1/2012

NCT03162458 Phase 3 COMPLETED

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

Started: 1/22/2015

NCT01535014 Phase 3 COMPLETED

Clinical Trial of Safety and Efficacy of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients

Started: 12/12/2011

NCT05605938 Phase 4 COMPLETED

Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety Disorders

Started: 7/28/2010

NCT03119766 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

Started: 6/28/2017

NCT03039621 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Started: 10/7/2016

NCT03485495 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

Started: 4/12/2018

NCT03036293 Phase 4 COMPLETED

Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders

Started: 2/8/2017

NCT03159091 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

Started: 6/16/2017

NCT03039699 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

Started: 6/23/2016

NCT03707912 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

Started: 10/9/2018

NCT03301155 Phase 4 COMPLETED

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

Started: 10/3/2017

NCT01850446 Phase 4 COMPLETED

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Started: 2/20/2015

NCT02072174 Phase 4 COMPLETED

Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

Started: 10/8/2014

NCT01868646 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

Started: 5/7/2013

NCT01868594 Phase 4 COMPLETED

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

Started: 5/7/2013

NCT01804946 Phase 4 COMPLETED

Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

Started: 2/1/2011

Drug Candidates

Raphamin Placebo Rengalin Ergoferon MMH-MAP Prospekta Tenoten for children MMH-407 Kolofort Dietressa
Activity Status: Active
Last Trial Started: 10/3/2025
Last Trial Ended: 3/19/2025
Trials (12 months): 1
Completed Trials: 33
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.